Search result for 'taro'

Sun Pharma arm, Taro, recalls over 17,000 units of antifungal shampoo in the US due to manufacturing issues. USFDA report details the recall.

FM Sitharaman inaugurates 4th Kautilya Economic Conclave 2025 on Oct 3. Theme: Seeking Prosperity in Turbulent Times. Key speakers include S Jaishankar.

Sun Pharma's subsidiaries settle US antitrust litigation, agreeing to pay USD 200 million to end purchaser plaintiffs. Settlement subject to court approval.

Elevation Capital appoints Krishna Mehra as Partner to lead AI investments, focusing on SaaS and AI startups in the India-US corridor.

Union Minister Ashwini Vaishnaw met Japan's Digital Transformation Minister Taro Kono, discussing digital collaboration and futuristic technological advancements.

Sun Pharma's consolidated net profit for Q1 FY25 jumped 40.2% to Rs 2,835.62 crore, driven by strong India formulation and global specialty sales growth.

Tomato prices have skyrocketed to Rs 100 per kg in Delhi due to supply disruptions caused by adverse weather conditions. Learn more about the impact on other vegetable prices.

Sun Pharma has completed the merger of Taro Pharmaceutical Industries, making Taro a wholly-owned subsidiary. The deal, valued at $347.73 million, brings together two pharmaceutical giants.

Taro shareholders have approved the company's merger with Sun Pharma, creating a combined entity to better serve patients and customers globally. The merger is expected to close in around 35 days.

Sun Pharma reported a 16.52% rise in its consolidated net profit to Rs 2,523.8 crore in Q3 FY24. Revenue from operations stood at Rs 12,380.7 crore, driven by growth in India and US formulations.

Sun Pharma to acquire remaining 21.52% stake in Taro Pharmaceutical Industries for Rs 2,891.76 crore, enabling the merger of the two entities.

Sun Pharma has revised its offer to acquire Taro Pharmaceutical Industries for USD 43 per share in cash, up from USD 38 per share. The deal is subject to shareholder approval.